glp 1 stocks Novo Nordisk to cut 9,000 jobs to compete in GLP-1 market Weight loss drugs and stocks:
Description
A study of health insurance claims found a 44% reduction in hospitalizations for GLP-1 users
Week 2+: Regular daily movements, burps gone, sustained energy and mental clarity
Background Bariatric surgery (BS) is the most effective treatment for severe obesity, but a significant proportion of patients experience insufficient weight loss (IWL) or weight regain
As doctors learn why GLP-1s don't work for about 50% of people, they are also learning more about the complex drivers of obesity
They now cost about Rs 1,0002,500 a month, and there's growing evidence pointing to benefits well beyond weight loss, including cardiovascular, metabolic, and liver health
